The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences There's a lot of noise around peptides right now so here's what actually changed. The FDA has begun reviewing several peptides that were previously placed on its do not compound list. By New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,